A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...

Last month, the European Medicines Agency allowed Novo to add risk reduction for events related to kidney disease to the ...

A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans a ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing kidney failure risk, disease progression, and death due to ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side effects.

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves ...

Novo Nordisk said on Tuesday the U.S. FDA has approved its blockbuster drug Ozempic to lower the risk of progression of ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...